Third-degree AV block from extended-release diltiazem ingestion in a nine-month-old
Brandon K Wills1, J Marc Liu, Michael Wahl
1Department of Emergency Medicine, Madigan Army Medical Center, Tacoma, Washington 98431, USA.
Insights
A 9-month-old infant experienced third-degree atrioventricular block and hypotension after ingesting extended-release diltiazem. This case highlights limited experience with pediatric calcium channel blocker overdose and its severe cardiac implications.
Area of Science:
- Pediatric Toxicology
- Cardiology
- Emergency Medicine
Background:
- Calcium channel blocker (CCB) overdose commonly causes cardiac dysrhythmias and atrioventricular (AV) block in adults.
- Limited clinical experience exists regarding CCB overdose in infants, necessitating case reports for understanding potential toxicity.
Observation:
- A 9-month-old infant presented to the Emergency Department (ED) after ingesting extended-release diltiazem.
- Initial vital signs revealed bradycardia (pulse 87 bpm) and hypotension (BP 72/48 mm Hg).
- Electrocardiogram demonstrated third-degree AV block with a ventricular rate of 90 bpm.
Findings:
- The infant developed third-degree atrioventricular block and hypotension following diltiazem ingestion.
- Initial treatment with atropine and calcium gluconate temporarily improved heart rate.
- The patient spontaneously converted to a normal sinus rhythm on hospital day 2 and was discharged.
Implications:
- This case underscores the potential for severe cardiac toxicity, including third-degree AV block, in infants following diltiazem overdose.
- It emphasizes the need for prompt recognition and management of CCB overdose in pediatric patients.
- Further research and case documentation are crucial for improving treatment protocols for infant CCB poisoning.
Abstract:
Calcium channel blocker (CCB) overdose is associated with dysrhythmias and atrioventricular (AV) block, however, experience with infant CCB overdose is limited. A 9-month-old girl was found playing with tablets of extended-release diltiazem 120 mg. The patient had two episodes of emesis, which contained pill fragments, and was brought to the Emergency Department (ED) 4.5 h after being found. Vital signs were: rectal temperature 37.1 degrees C, pulse 87 beats/min, respiratory rate 30-40 breaths/min, blood pressure 72/48 mm Hg, and oxygen saturation (SpO(2)) 99% on room air. Otherwise, the patient was well-appearing, with normal skin color and examination. The electrocardiogram revealed third-degree atrioventricular block with a ventricular rate of 90 beats/min, QRS 68 ms, and QTc 411 ms. Atropine 0.1 mg i.v. was given, which increased the heart rate to 100-110 beats/min. Calcium gluconate 500 mg was also given intravenously. Laboratory evaluation revealed bicarbonate 17 mEq/L, anion gap 16, and glucose 129 mg/dL. On hospital day 1, the patient was noted to have a junctional rhythm with a rate of 90-100, and systolic blood pressure of 80-90 mm Hg. No additional medications were given. Early on day 2, the patient converted spontaneously to a normal sinus rhythm and was discharged approximately 42 h after presentation to the ED. In addition to bradycardia and hypotension, this 9-month-old patient manifested third-degree AV block after ingesting extended-release diltiazem.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...


